VetraSeb CK Wipes

This page contains information on VetraSeb CK Wipes for veterinary use.
The information provided typically includes the following:

VetraSeb CK Wipes Indications
Warnings and cautions for VetraSeb CK Wipes
Direction and dosage information for VetraSeb CK Wipes

VetraSeb CK Wipes

This treatment applies to the following species:

Cats
Dogs

Company: VetOne

Chlorhexidine Gluconate 2%, Ketoconazole 1%, Phytosphingosine salicyloyl 0.04%

Antiseptic Wipes + PS for Dogs and Cats

Phytosphingosine

Active Ingredients

Chlorhexidine Gluconate 2%, Ketoconazole 1%, Phytosphingosine salicyloyl 0.04%.

Inactive Ingredients

Water, Propylene Glycol, Nonoxynol-9, Lactic Acid, Polysorbate 20, Glycerin, Fragrance.

INDICATION: For use on dogs and cats only. For local antiseptic cleansing.

Directions For Use

Wipe the targeted area one to three times a day or as directed by your veterinarian. Do not allow the animal to lick the treated area until dry. Wipes should be used for one application only. Do not reuse.

CAUTIONS: For external use on dogs and cats only. Avoid contact with the eyes. In case of contact with eyes, rinse thoroughly and consult your veterinarian. If skin irritation occurs or increases, discontinue use and consult with your veterinarian.

Warning

Keep out of the reach of children.

STORAGE CONDITIONS: Store at room temperature. Do not freeze.

Authorized for sale through licensed veterinarians only.

Distributed by: MWI, Boise, Idaho 83705

www.VetOne.net

Questions? 1-800-999-0297

Net Content:

NDC

60 Wipes

13985-734-60

V1 600127

FSCHLKPS3060MW

F35210E-US 16-A1-v1

CPN: 1315237.1

VET ONE
Distributed by MWI Animal Health
3041 W. PASADENA DR., BOISE, ID, 83705

Customer Service:		888-694-8381
Toll-Free:		800-824-3703
Website:		www.mwianimalhealth.com
		www.vetone.net

THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.